Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (181-190 of 512) with videos related to

Pageof 52
Sort By:
Targeted Oncology|August 15, 2014
Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLCCecile Bosc, Gilbert R Ferretti, Jacques Cadranel, et al.
Tumori|May 21, 2016
Crizotinib primary resistance overcome by ceritinib in a patient with ALK-rearranged non-small cell lung cancerFrancesco Facchinetti, Caroline Caramella, Nathalie Auger, et al.
Clinical Lung Cancer|March 26, 2017
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613Jordi Remon, Jessica Menis, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Translational Lung Cancer Research|July 23, 2021
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2013
First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patientAntoine Hollebecque, Antonin Levy, Sophie Broutin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2014
Synaptic release of CCL5 storage vesicles triggers CXCR4 surface expression promoting CTL migration in response to CXCL12Katarzyna Franciszkiewicz, Marie Boutet, Ludiane Gauthier, et al.
Clinical Lung Cancer|September 27, 2024
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung CancerMay-Lucie Meyer, Louis Gros, Natalie Décosterd, et al.
Respiratory Medicine and Research|November 12, 2022
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitorsMarion Camard, Benjamin Besse, Pierre-Louis Cariou, et al.
Pageof 52

Showing results (181-190 of 512) with videos related to

Sort By:
Pageof 52
Targeted Oncology|August 15, 2014
Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLCCecile Bosc, Gilbert R Ferretti, Jacques Cadranel, et al.
Tumori|May 21, 2016
Crizotinib primary resistance overcome by ceritinib in a patient with ALK-rearranged non-small cell lung cancerFrancesco Facchinetti, Caroline Caramella, Nathalie Auger, et al.
Clinical Lung Cancer|March 26, 2017
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613Jordi Remon, Jessica Menis, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Translational Lung Cancer Research|July 23, 2021
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2013
First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patientAntoine Hollebecque, Antonin Levy, Sophie Broutin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2014
Synaptic release of CCL5 storage vesicles triggers CXCR4 surface expression promoting CTL migration in response to CXCL12Katarzyna Franciszkiewicz, Marie Boutet, Ludiane Gauthier, et al.
Clinical Lung Cancer|September 27, 2024
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung CancerMay-Lucie Meyer, Louis Gros, Natalie Décosterd, et al.
Respiratory Medicine and Research|November 12, 2022
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitorsMarion Camard, Benjamin Besse, Pierre-Louis Cariou, et al.
Pageof 52